Complexation of histone deacetylase inhibitor belinostat to Cu(II) prevents premature metabolic inactivation in vitro and demonstrates potent anti-cancer activity in vitro and ex vivo in colon cancer
Ellen Finnegan, Sudipto Das(National Cancer Institute), Alexander Kel(Royal College of Surgeons in Ireland), Gráinne Kirwan, Xiaofei Yin(Broad Institute), Xinxin Shao(Shandong University of Technology), Darran P. O’Connor, Celine J. Marmion(Royal College of Surgeons in Ireland), Anna Blümel(Royal College of Surgeons in Ireland), Lorraine Brennan(University College Dublin), Sally‐Ann Cryan(Royal College of Surgeons in Ireland), Flavia Genua, Jochen H.M. Prehn(Royal College of Surgeons in Ireland), Gregory S. Yochum(Oregon Health & Science University), Parvathi A. Myer(Albert Einstein College of Medicine), Žiga Ude, Sara Terer, Wei Ding(Capital Medical University), T.J.P. McGivern, Sarinj Fattah
Cited by 7
Related Papers
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
|Nature Genetics|2006|657
Metabolomics enables precision medicine: “A White Paper, Community Perspective”
|Metabolomics|2016|615
PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
|Cancer Discovery|2017|336
Activation of Calpain I Converts Excitotoxic Neuron Death into a Caspase-independent Cell Death
|Journal of Biological Chemistry|2000|264